Pulmonary bacterial co-infections and antibiotical resistance in SARS-COV-2: the dark coalescence of post-COVID-19 world

Background. A third wave of COVID-19 infection is now sweeping across the globe. Severe injury epithelial barrier, caused by action respiratory viruses (including coronaviruses), facilitates invasion tract with other germs, like viruses, fungy or bscteria. Methods. 92 inpatients pneumonia and 68 nosocomial (NP) non were enrolled in our study. For microbiological assessment sputum samples collected. Statistical analysis performed using x2 test (Statistica software, version 7.0). Results. From patients 64 (69,2%) dignosed secondary bacterial (SNBI). Overall ESKAPE agents, K.pneumoniae, E.faecium, Acinetobacter spp. Ps.aeruginosa highly detected SARS- CoV-2 group — 85,7%. opposed to group, agents isolated from SARS-CoV-2 SNBI manifested higher rate antibiotical panresistance (p < 0,05). Conclusions. The study showed some etiological antibiotic resistance differences SNBI, compared NP a group. Thus, empirical treatment co-infections requires proven argumentation adjustment data each case separately.